Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcome of adult acute lymphoblastic leukemia in Lebanon: a single institution experience from the American University of Beirut.
Charafeddine KM, Hatoum HA, Otrock ZK, Mahfouz RA, Salem ZM, Shamseddine AI, Taher AT, El-Saghir NS, Bazarbachi A. Charafeddine KM, et al. Among authors: hatoum ha. Hematol Oncol Stem Cell Ther. 2009;2(2):333-9. doi: 10.1016/s1658-3876(09)50021-0. Hematol Oncol Stem Cell Ther. 2009. PMID: 20118056 Free article. Clinical Trial.
Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation.
Otrock ZK, Hatoum HA, Salem ZM, Tawil A, Mahfouz RA, Zaatari GS, Bazarbachi A. Otrock ZK, et al. Among authors: hatoum ha. Ann Hematol. 2008 Dec;87(12):1023-4. doi: 10.1007/s00277-008-0523-7. Epub 2008 Jun 28. Ann Hematol. 2008. PMID: 18587577 No abstract available.
Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.
Hatoum HA, Jamali FR, El-Saghir NS, Musallam KM, Seoud M, Dimassi H, Abbas J, Khalife M, Boulos FI, Tawil AN, Geara FB, Salem Z, Shamseddine AA, Al-Feghali K, Shamseddine AI. Hatoum HA, et al. Ann Surg Oncol. 2009 Dec;16(12):3388-95. doi: 10.1245/s10434-009-0653-8. Ann Surg Oncol. 2009. PMID: 19655200 Clinical Trial.
Is VEGF a predictive biomarker to anti-angiogenic therapy?
Otrock ZK, Hatoum HA, Musallam KM, Awada AH, Shamseddine AI. Otrock ZK, et al. Among authors: hatoum ha. Crit Rev Oncol Hematol. 2011 Aug;79(2):103-11. doi: 10.1016/j.critrevonc.2010.07.008. Epub 2010 Aug 17. Crit Rev Oncol Hematol. 2011. PMID: 20724177 Review.
22 results